Planta Med 2019; 85(18): 1561-1562
DOI: 10.1055/s-0039-3400131
Main Congress Poster
Poster Session 2
© Georg Thieme Verlag KG Stuttgart · New York

STW 5 in 1515 patients with functional gastrointestinal diseases

J Möller
1   Bayer Consumer Health, Innovation & Development, Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH,, Havelstr. 5, 64295 Darmstadt, Germany
,
E Raskopf
2   ClinNovis GmbH,, Genter Str. 7, 50672 Cologne, Germany
3   Institute for Medical Statistics and Computational Biology, University Hospital Cologne,, Kerpener Str. 62, 50937 Cologne, Germany
,
O Greinert
3   Institute for Medical Statistics and Computational Biology, University Hospital Cologne,, Kerpener Str. 62, 50937 Cologne, Germany
,
G Zadoyan
3   Institute for Medical Statistics and Computational Biology, University Hospital Cologne,, Kerpener Str. 62, 50937 Cologne, Germany
,
S Schleicher
3   Institute for Medical Statistics and Computational Biology, University Hospital Cologne,, Kerpener Str. 62, 50937 Cologne, Germany
,
K Shah-Hosseini
3   Institute for Medical Statistics and Computational Biology, University Hospital Cologne,, Kerpener Str. 62, 50937 Cologne, Germany
,
T Wegener
4   Kooperation Phytopharmaka GbR,, Plittersdorfer Str. 218, 53173 Bonn, Germany
5   Consulting HMP,, Brückstr. 11, 69469 Weinheim, Germany
,
O Kelber
1   Bayer Consumer Health, Innovation & Development, Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH,, Havelstr. 5, 64295 Darmstadt, Germany
4   Kooperation Phytopharmaka GbR,, Plittersdorfer Str. 218, 53173 Bonn, Germany
,
J Singh
2   ClinNovis GmbH,, Genter Str. 7, 50672 Cologne, Germany
3   Institute for Medical Statistics and Computational Biology, University Hospital Cologne,, Kerpener Str. 62, 50937 Cologne, Germany
,
K Kraft
4   Kooperation Phytopharmaka GbR,, Plittersdorfer Str. 218, 53173 Bonn, Germany
6   Lehrstuhl für Naturheilkunde, Universitätsmedizin Rostock,, Ernst-Heydemann Str. 6, 18057 Rostock, Germany
,
K Nieber
4   Kooperation Phytopharmaka GbR,, Plittersdorfer Str. 218, 53173 Bonn, Germany
7   Institute of Pharmacy, University of Leipzig,, Brüderstr. 34, 04103 Leipzig, Germany
,
R Mösges
2   ClinNovis GmbH,, Genter Str. 7, 50672 Cologne, Germany
3   Institute for Medical Statistics and Computational Biology, University Hospital Cologne,, Kerpener Str. 62, 50937 Cologne, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
20 December 2019 (online)

Also available at
 
 

Herbal medicinal products are an important treatment option for patients with functional gastrointestinal diseases (FGID). Data on the use of STW 5 [1] in FGID were selected from the PhytoVIS study, a non-interventional study in 20,870 patients who had used a herbal product within the last 8 weeks before the survey [2]. The aim was to describe the epidemiology, medical needs and the perceived effect of the therapy in these patients.

Questionnaires related to STW 5 were evaluated regarding epidemiological data on gender, age and disease state as well as on the use of the medicine and its perception.

From the PhytoVIS data 1515 patients taking STW 5 could be identified. About two thirds of the patients had symptoms associated with FD, ca. one third associated with FD or IBS. 94% of patients reported the therapeutic experience to be moderate or better, 63% stated it to be very good, with 30% of all patients experiencing an effect after a few minutes, 80% after some hours. Side effect profile and tolerability of STW 5 were convincing.

PhytoVIS turned out to be a suitable tool to study the epidemiology of patients with functional GI diseases treated with STW 5. STW 5 proved to be a fast-acting therapeutic option rated positive not only in a vast variety of gastrointestinal complaints, but also regardless of factors like the age of the patients, thus making it an interesting option for vulnerable patient groups and patients suffering from often multi-causal gastrointestinal diseases with different symptoms.

Zoom Image
Fig. 1

#

Acknowledgment

The study is supported by Kooperation Phytopharmaka GbR, Bonn, Germany

  • References

  • 1 Malfertheiner P. STW 5 (Iberogast) therapy in gastrointestinal functional disorders. Dig Dis 2017; 35 (Suppl):1: 25
    PubMedGoogle Scholar
  • 2 Raskopf E, Greinert O, Zadoyan G, Schleicher S, Shah-Hosseini K, Meng G. et al. Health care research in phytomedicine: PhytoVIS, a NIS in 20.870 users of herbal medicinal products. GA Congress Shanghai 2018, PO-1252
    PubMedGoogle Scholar

  • References

  • 1 Malfertheiner P. STW 5 (Iberogast) therapy in gastrointestinal functional disorders. Dig Dis 2017; 35 (Suppl):1: 25
    PubMedGoogle Scholar
  • 2 Raskopf E, Greinert O, Zadoyan G, Schleicher S, Shah-Hosseini K, Meng G. et al. Health care research in phytomedicine: PhytoVIS, a NIS in 20.870 users of herbal medicinal products. GA Congress Shanghai 2018, PO-1252
    PubMedGoogle Scholar

 
Zoom Image
Fig. 1